跳至主要内容
临床试验/NCT06778811
NCT06778811招募中4 期

Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery

Nanjing First Hospital, Nanjing Medical University2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2024年10月11日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
180
试验地点
2
主要终点
Sleep Quality

研究概览

简要总结

The aim of this clinical trial is to understand the effects of dexmedetomidine and esketamine on postoperative sleep in patients undergoing cardiac surgery. The main questions it aims to answer are:

Does dexmedetomidine or esketamine prevent the development of postoperative sleep disturbances? Which one works better? The researchers compared dexmedetomidine and esketamine with saline (a drug-free solvent) to see if dexmedetomidine and esketamine prevented the development of postoperative sleep disturbances.

Participants will:

  1. Intraoperative continuous infusion of dexmedetomidine, esketamine or saline until the end of surgery
  2. Postoperative sleep was assessed on the first and third postoperative days using a sleep rating scale

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA class II-III, NYHA class I-III, EF ≥ 50%
  • Intended to perform cardiac surgery under extracorporeal circulation

排除标准

  • Patients undergoing second heart surgery
  • Patients with mental retardation, deafness, or other conditions that interfere with normal communication
  • Previous neurological or psychiatric disorders
  • Patients with a history of sleep disorders
  • Alcoholics, drug addicts, or psychotropic substance abusers
  • Significant hepatic or renal dysfunction affecting drug metabolism
  • Contraindication to the use of dexmedetomidine or esketamine.

研究组 & 干预措施

dexmedetomidine group

Experimental

Intraoperative infusion of 0.3ug/kg/h dexmedetomidine

干预措施: Intraoperative infusion of dexmedetomidine (Drug)

esketamine group

Experimental

Intraoperative infusion of 0.3mg/kg/h esketamine

干预措施: Intraoperative infusion of esketamine (Drug)

control group

Placebo Comparator

Intraoperative infusion of equal volumes of saline

干预措施: Saline control (Drug)

结局指标

主要结局

Sleep Quality

时间窗: 1, 3, 7days after surgery

Assessment of sleep quality by the Athens Insomnia Scale (AIS) and smart wearable device

次要结局

  • anxiety and depression assessment(1,3 days after surgery)
  • Postoperative complications(48 hours after surgery)
  • postoperative pain(24 hours and 48 hours after surgery)
  • Record postoperative analgesic medications used and the amount used for postoperative pain(24 hours and 48 hours after surgery)
  • Postoperative delirium(from 1 day to 7 days after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验